Abstract
Multi drug hypersensitivity syndrome (MDHS) is often challenging as it endangers patient compliance as well as treatment failure. It develops due to dysregulated cell mediated immunity that results in drug hypersensitivity reactions (DHR) and is characterized by severe exanthems or drug rash with eosinophilia &systemic symptoms (DRESS).
DHR is very common among patients on anti-tubercular therapy (ATT) for Pulmonary as well as Extra-Pulmonary Tuberculosis (EPTB), particularly with 1st line anti tubercular drugs like ethambutol, pyrazinamide, Rifampicin & Isoniazid. But reporting of MDHS has been low in India, despite having high burden of tuberculosis.
A 13-year-old female child, on ATT for Tubercular Meningitis (TBM), presented to us with DHR, was found out to have MDHS and was managed tactfully with an alternate regimen.
TB meningitis is a severeform of EPTB that needs aggressive treatment to avoid neurological complications & sequelae.
For these patients, it was crucial to identify the offending drug as soon as possible and restart a suitable alternate regimen in order to reduce morbidity and mortality.
Keywords: MDHS, EPTB, TB-Meningitis, ATT.
References
- Gex-Collet C, Helbling A, Pichler WJ. Multiple drug hypersensitivity – proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. J Investig Allergol Clin Immunol. 2005;15: 293–296. [PubMed] [Google Scholar] [Ref list]
- Neukomm CB, Yawalkar N, Helbling A, Pichler WJ. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J InvestigAllergolClinImmunol. 2001;11:275–284. [PubMed] [Google Scholar] [Ref list]
- Pichler WJ, Srinoulprasert Y, Yun J, Hausmann O. Multiple Drug Hypersensitivity. Int Arch Allergy Immunol. 2017;172(3):129-138. doi: 10.1159/000458725. Epub 2017 Mar 18. PMID: 28315874; PMCID: PMC5472211.
- Daubner B, Groux-Keller M, Hausmann OV, Kawabata T, Naisbitt DJ, Park BK, Wendland T, Lerch M, Pichler WJ. Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells. Allergy. 2012;67:58–66. [PubMed] [Google Scholar] [Ref list]
- Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Recurrence of drug-induced reactions in DRESS patients. J EurAcadDermatolVenereol. 2015:801–804. [PubMed] [Google Scholar] [Ref list]
- Studer M, Waton J, Bursztejn AC, Aimone-Gastin I, Schmutz JL, Barbaud A. Does hypersensitivity to multiple drugs really exist? Ann Dermatol Venereol. 2012;139:375–380. [PubMed] [Google Scholar] [Ref list]
- Attaway NJ, Jasia M, Sullivan T. Familial drug allergy. J Allergy ClinImmunol. 1991;87:227. [Google Scholar] [Ref list]
- Kurtz KM, Beatty TL, Adkinson NF., Jr Evidence for familial aggregation of immunologic drug reactions. J Allergy ClinImmunol. 2000;105:184–185. [PubMed] [Google Scholar] [Ref list]
- Kempker RR, Smith AGC, Avaliani T, Gujabidze M, Bakuradze T, Sabanadze S, Avaliani Z, Collins JM, Blumberg HM, Alshaer MH, Peloquin CA, Kipiani M. Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness. Clin Infect Dis. 2022 Sep 10;75(4):682-689. doi: 10.1093/cid/ciab992. PMID: 34849645; PMCID: PMC9464073.
- Ethical Consideration: Informed consent was taken from guardian of patient regarding drug provocation test and publication of the data in journal.
Corresponding Author
Anirban Saha
Junior Resident, Dept. of Pulmonary Medicine, VIMSAR, Burla, Odisha, India
DOI: https://dx.doi.org/10.18535/jmscr/v11i2.06
